S6E05: Francesca DeMartino from Pfizer on Science Meets Story: Inside the IR Program at One of the World's Biggest Pharma Companies

At a company as large and complex as Pfizer, investor relations isn't just about answering questions. It's about architecting a story that works for a PhD and a generalist in the same room. In this episode of Winning IR, Mark Fasken speaks with Francesca DeMartino, Chief Investor Relations Officer at Pfizer, about what it takes to run a world-class IR program inside one of the most scientifically complex, brand-recognizable, and closely scrutinized companies on the planet. Drawing on over 25 years of experience across pharma, med tech, investment banking, and corporate communications, Francesca shares how she builds her bench, controls the narrative, and earns her seat at the table.Listen to the full episode to learn more about:Why pharma IR is unlike any other sector and what IROs everywhere can learn from itHow to tailor your story for generalist and specialist investors, sometimes in the very same meetingWhy Francesca abandoned traditional Q&A documents in favor of message maps and why you should tooHow to build an IR team that is truly fit for purpose, and what skill sets matter mostThe three pillars of a great IR program: storytelling, consensus management, and targeting — and how to master all threeWinning IR is brought to you by Irwin. For more winning ideas, subscribe to Winning IR wherever you get your podcasts.For more information, visit getirwin.com/winning-ir